Follow Us
https://www.thebody.com/category/isentress-raltegravir-mk0518/tag/news

The Latest

Promo Image

Switching Isentress to Once a Day Is Less Effective

Although the integrase inhibitor Isentress (raltegravir) is recommended for people going on treatment for the first time, it's the only first line drug that's taken twice, not once, a day. In an effort to simplify the dosing, a study compared taking ...

Promo Image

New Experimental Drug Integrase Inhibitor (MK-0518)

For the last six years, treatment has driven the AIDS agenda. Just this past summer, the Food and Drug Administration (FDA) approved Prezista, a new Protease Inhibitor, as well as Atripla, the first once-daily single tablet regiment for adults with...